---
title: "Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286464989.md"
description: "Abbott Laboratories (ABT) shares rose 1.28% to $84.90 on a strong trading day, outperforming competitors like Johnson & Johnson (JNJ) and Pfizer Inc. (PFE). The S&P 500 Index increased by 0.77%, while Abbott remains 38.95% below its 52-week high of $139.06. Trading volume was 10.9 million, below the 50-day average of 12.9 million. This information was generated by MarketWatch."
datetime: "2026-05-14T20:36:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286464989.md)
  - [en](https://longbridge.com/en/news/286464989.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286464989.md)
---

# Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Abbott Laboratories (ABT) advanced 1.28% to $84.90 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.77% to 7,501.24 and the Dow Jones Industrial Average rising 0.75% to 50,063.46.

Abbott Laboratories closed 38.95% short of its 52-week high of $139.06, which the company reached on June 24th.

The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 0.16% to $230.80, Pfizer Inc. (PFE) fell 0.81% to $25.75, and Merck & Co. Inc. (MRK) fell 0.04% to $113.41.

Trading volume (10.9 M) remained 2.0 million below its 50-day average volume of 12.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 14, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-14-26 1636ET

### Related Stocks

- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)

## Related News & Research

- [Rayburn West Financial Services LLC Buys Shares of 16,587 Abbott Laboratories $ABT](https://longbridge.com/en/news/286395934.md)
- [NVision Expands from Quantum Sensing to Quantum Computing to Accelerate Discovery and Validation of New Therapies](https://longbridge.com/en/news/286239950.md)
- [3 'Strong Buy' Dividend Aristocrat Stocks with 100%+ Payout Ratios, 5/14/26](https://longbridge.com/en/news/286462897.md)
- [Edwards Lifesciences CVP, Strategy/Corp Development Sold Shares Worth Over $1.4M](https://longbridge.com/en/news/286822028.md)
- [Stryker Buys Amplitude Vascular Systems For Upto $835 Mln To Expand Vascular Treatment Business](https://longbridge.com/en/news/286889480.md)